European shares rise on vaccination hopes, information from China; Brexit talks with eyes
© Reuters. The German stock index DAX graphic on the Frankfurt Stock Exchange
(Reuters) – European stocks got off to a positive start to December on Tuesday. Optimism about a coronavirus vaccine has bolstered arguments for an economic recovery and primed stocks for an extension of record profits in November.
After a downturn when investors took some profits at the end of a spectacular month, the pan-European index was back in the black, up 0.3%.
The index ended November up almost 14%.
A company survey that further bolstered sentiment confirmed the official figures from the previous day, which showed robust growth in Chinese factory activity. Similar dates from Europe are due later in the day.
However, uncertainties surrounding a Brexit trade deal kept profits in check. The European Union will take emergency measures on Wednesday or Thursday if it can’t reach an agreement with the UK by then, a senior EU diplomat said on Monday.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. As a result, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading loss you may incur as a result of using this information.
Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please be fully informed about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.